Investors

Insider Transactions

Date Name Title Type Shares Traded Sorted Ascending Price Range
May 18, 2012 shooter eric m Director Option Execute 2,000 18.61
Dec 20, 2012 van plew daniel p Officer Option Execute 2,050 16.80
Apr 17, 2012 baker charles a Director Automatic Sell 2,090 125.00
Apr 17, 2012 baker charles a Director Option Execute 2,090 18.80
Aug 8, 2014 stahl neil Officer Sell 2,100 340.60 - 341.00
Dec 20, 2010 brown michael s Director Automatic Sell 2,103 32.89 - 33.24
Jan 28, 2010 roberts william Officer Automatic Sell 2,119 26.53 - 27.05
May 2, 2013 mccorkle douglas s Officer Automatic Sell 2,213 241.45 - 247.21
Feb 10, 2011 goldstein joseph l Director Automatic Sell 2,239 35.27
Jan 26, 2012 goldberg murray a Officer Disposition (Non Open Market) 2,250 n/a
Dec 12, 2008 roberts william Officer Disposition (Non Open Market) 2,400 n/a
Dec 12, 2008 roberts william Officer Acquisition (Non Open Market) 2,400 n/a
Dec 21, 2009 mccorkle douglas s Officer Automatic Sell 2,456 22.00
Dec 21, 2009 mccorkle douglas s Officer Option Execute 2,456 8.50
Dec 20, 2011 goldberg murray a Officer Option Execute 2,500 11.64
Aug 20, 2008 goldstein joseph l Director Disposition (Non Open Market) 2,500 n/a
May 31, 2013 ryan arthur f Director Sell 2,500 249.45 - 249.58
Nov 13, 2009 sing george l Director Buy 2,500 18.68 - 18.72
May 18, 2010 sing george l Director Buy 2,500 28.64
Aug 8, 2014 vagelos p roy Officer Sell 2,600 340.33
Showing 81-100 of 841 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)